Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Not all Roth withdrawals are qualified. This primer outlines which withdrawals meet the qualified distribution criteria and how to maximize tax efficiency.
19,626 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
A Friday announce could insert Marvell into the S&P 500 after a dramatic stock surge. The company's market cap dwarfs...
Industrial stocks can offer big turns with the right cycle. This guide shows how to analyze backlog, margins, and ris...
As roughly $1.8 billion in crypto options approach expiration on Deribit, traders weigh whether will markets continue...
Meta posted solid earnings, yet the stock slipped. This guide breaks down why and how to decide if the pullback creat...
POET Technologies has logged a 220% surge over the past year, but traders are contending with signs of a potential co...
Bitcoin tumbled to $59,000 last Friday, the lowest in months, sparking a debate among traders about whether a bottom ...
A growing clash over baseball economics enters a new phase as Trump signals support for a hard salary cap in MLB, int...
NVIDIA CEO Jensen Huang signaled a bigger AI opportunity ahead for Tesla, suggesting the EV maker could outgrow its c...
A major AI and cloud deal is flanking SpaceX's IPO, potentially nudging investor sentiment. This article breaks down ...
The EUAD ETF has rebounded, prompting investors to focus on three defense stocks to watch as European budgets firm up...
After years of eye-popping gains, investors wonder if Nvidia and Broadcom still have room to run. This guide uses his...